NCT05485441

Brief Summary

To date, there have been no interventional studies aimed at increasing HPV vaccination rates by making use of digital and involving all stakeholders within this process: nurses, physicians, caregivers, parents, and children/adolescents according to the PPI principle. The primary objective of the project is to identify the effectiveness of a digital educational intervention, conducted by a multidisciplinary healthcare team and targeting adolescents of both sexes in secondary schools. The outcome measures will be: engagement, increased knowledge and self-efficacy, and vaccination uptake. This project will identify new models for addressing public health needs. The secondary aim is to evaluate parents' attitudes toward vaccination pre- and post-intervention education. A quasi-experimental, pre-post educational intervention study will be conducted by adopting a convenience sampling will be adopted at secondary schools in Bari (Puglia, Italy).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 3, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

February 2, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

July 10, 2023

Status Verified

July 1, 2023

Enrollment Period

1.4 years

First QC Date

July 12, 2022

Last Update Submit

July 6, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Children's vaccination uptake

    Measured through a telephonic interview to parents, difference in vaccination rates (% before/after)

    90 days

  • Children's knowledge on HPV vaccination

    Measured through: (1) the Questionnaire - HAVIQ Adolescente Vaccine Intervention Questionnaire; 5-point Likert scale (from 1=strongly disagree to 5=strongly agree). (2) 10 items with dichotomous "yes/no" responses. Each correct answer will be assigned a score of 1, each answer not given or incorrect, zero. The total score ranges from 0 (no knowledge) to 10 (highest level of knowledge).

    90

  • Children's self-efficacy in receiving the vaccine

    Measured through the Questionnaire - HAVIQ Adolescente Vaccine Intervention Questionnaire; 100-point scale (0="not at all confident"; 100="completely confident").

    90

  • Children's fear and anxiety towards vaccination

    Measured through the Questionnaire - HAVIQ Adolescente Vaccine Intervention Questionnaire; 5-point Likert scale (from 1=strongly disagree to 5=strongly agree)

    90

  • Children's involvement in vaccine decision making

    Measured through the Questionnaire - HAVIQ Adolescente Vaccine Intervention Questionnaire; 5-point Likert scale (from 1=strongly disagree to 5=strongly agree)

    90

Secondary Outcomes (1)

  • Parent's hesitancy about vaccination

    90 days

Study Arms (2)

Students

EXPERIMENTAL

The students

Other: Digital Educational Intervention

Parents

EXPERIMENTAL

The parents

Other: Digital Educational Intervention

Interventions

The educational intervention will be provided (at T1) in two ways: (I) a video lecture in e-learning mode lasting about an hour, aimed at adolescents, using the School Institute's platform for distance education (II) the promotion of 2-minute "videopills" on the social channels most frequently used by students (dedicated youtube channel/school portal)

ParentsStudents

Eligibility Criteria

Age11 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Students aged 11- 13 years and their parents.
  • Students with disabilities, with visual and hearing impairment, with the suppor of their support teacher.

You may not qualify if:

  • Students and/or parents who do not agree to participate
  • Students and/or parents who do not provide informed consent
  • Students and/or parents who do not provide a telephone number and e-mail address to be contacted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Aldo Moro of Bari

Bari, Apulia, 70124, Italy

RECRUITING

Related Publications (4)

  • Napolitano F, D'Alessandro A, Angelillo IF. Investigating Italian parents' vaccine hesitancy: A cross-sectional survey. Hum Vaccin Immunother. 2018 Jul 3;14(7):1558-1565. doi: 10.1080/21645515.2018.1463943. Epub 2018 May 14.

    PMID: 29641945BACKGROUND
  • Forster AS, McBride KA, Davies C, Stoney T, Marshall H, McGeechan K, Cooper SC, Skinner SR. Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health. 2017 Jun;147:77-83. doi: 10.1016/j.puhe.2017.02.006. Epub 2017 Mar 18.

    PMID: 28404501BACKGROUND
  • Opel DJ, Taylor JA, Mangione-Smith R, Solomon C, Zhao C, Catz S, Martin D. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine. 2011 Sep 2;29(38):6598-605. doi: 10.1016/j.vaccine.2011.06.115. Epub 2011 Jul 16.

    PMID: 21763384BACKGROUND
  • Gottvall M, Tyden T, Hoglund AT, Larsson M. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS. 2010 Aug;21(8):558-62. doi: 10.1258/ijsa.2010.010063.

    PMID: 20975088BACKGROUND

Study Officials

  • Giancarlo Cicolini

    Researcher

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 12, 2022

First Posted

August 3, 2022

Study Start

February 2, 2023

Primary Completion

July 1, 2024

Study Completion

August 1, 2024

Last Updated

July 10, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations